Cancer Diagnosis
Jul 20, 2021
MedTech Wrap Up
Neuros Medical Receives FDA Breakthrough Device Designation for its Novel Altius® High-Frequency Nerve Block System On June 29, 2021, the US Food and Drug Administration (FDA) granted Neuros Medical, Inc. Breakthrough Device Designation for the use of their unique Altius High-Frequency Nerve Block device in...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
